在急性中风决策和全球评估中平衡康复剂量 (桥梁研究)
Shinichi Watanabe1,2, Wataru Yamauchi3, Katsuma Shoka4
1Department of Physical Therapy, Faculty of Rehabilitation, Gifu University of Health Science, Gifu 500-8281, Japan.
Journal of clinical medicine
|October 16, 2025
概括
这项研究调查了早期康复强度对日本中风恢复的影响. 它旨在定义最佳的康复剂量,以改善功能结果并减少中风后的残疾.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 临床研究 临床研究
背景情况:
- 在日本,中风是导致残疾的主要原因.
- 早期动员对于预防肌肉缩和加强中风后的独立性至关重要.
- 对于急性中风患者的最佳康复强度和持续时间仍未确定.
研究的目的:
- 检查中风急性阶段的康复剂量与中风发病90天后的功能结果之间的关联.
- 为个性化,基于证据的动员策略提供证据.
- 为了优化中风患者的功能结果.
主要方法:
- 在日本的12家急性护理医院进行多中心前性队列研究.
- 招募年龄≥18岁,住院时间≥7天的患者,在中风后的第二天开始康复.
- 使用动员量化得分 (MQS) 量化康复剂量;初级结局是90天后修改的兰金度量表 (mRS).
主要成果:
- 这是一个研究方案; 结果尚未提供.
- 这项研究旨在澄清早期康复剂量与中风后功能恢复之间的关系.
结论:
- 这是日本首次使用标准化工具评估早期中风康复剂量的大规模研究.
- 预计这些发现将为中风患者的最佳动员策略提供信息.
- 将提供基于证据的个人化康复建议.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522


